- Corporate Officers - R
- Roemer Alan S.
Insider Trading History of Roemer Alan S.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Roemer Alan S. since 2021.
This trader's CIK number is 1643070.
At the time of last reporting, Roemer Alan S. was the Officer of In8bio, Inc.. (stock ticker symbol INAB).
Also see all insider trading activities at In8bio, Inc..
Note that in the past
Roemer Alan S. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at In8bio, Inc. (INAB) by Roemer Alan S.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | INAB | 0 | $0 | 0 | $0 | 113,459 | $20,876 |
2022 | INAB | 26,315 | $49,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neximmune, Inc. (NEXI) by Roemer Alan S.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | NEXI | 0 | $0 | 7,825 | $16,042 | 0 | $0 |
2021 | NEXI | 0 | $0 | 0 | $0 | 67,657 | $209,939 |
Insider trading activities at 2 companies by Roemer Alan S.:
1. In8bio, Inc. (INAB)
2. Neximmune, Inc. (NEXI)
Table 1. Insider trading of In8bio, Inc. (INAB) by Roemer Alan S.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-04-30 | INAB | Option Ex | 113,459 | .18 | 20,876 |
2022-08-16 | INAB | Buy | 26,315 | 1.90 | 49,998 |
Table 2. Insider trading of Neximmune, Inc. (NEXI) by Roemer Alan S.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-11-22 | NEXI | Sale | 3,992 | 1.94 | 7,756 |
2023-11-21 | NEXI | Sale | 3,833 | 2.16 | 8,286 |
2021-12-21 | NEXI | Option Ex | 67,657 | 3.10 | 209,939 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Roemer Alan S.
(Officer of In8bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.